Gynecological NGS panels offer cost-effective cancer testing: Sounak Gupta, M.B.B.S., Ph.D.
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Sounak Gupta, M.B.B.S., Ph.D., explains how Mayo Clinic Laboratories' gynecological NGS panels provide focused assessments of gynecological cancers. The cost-effective tests fill the gap between single gene assays and large cancer panels, to inform prognosis and treatment.
(00:32)
Could you provide our listeners with a little bit about yourself and your background, please?
(01:22)
Could you give a brief overview of the new assays?
(03:55)
Can you talk a little about both the ovarian and gynecologic panel that will be in the new set of tests?
(05:53)
What patients will be impacted by this testing?
(07:51)
Can you speak to some of the individual genes in the gynecological area, such as POLE?
(09:31)
Is there anything else you would like to add?